WORLD LEADERS RECOGNIZED SCIENTIFIC LEADERS +20,000 SURGERIES PERFORMED
Specialized Procedure

HIPEC: Hyperthermic Intraperitoneal Chemotherapy

Combined treatment of cytoreductive surgery and heated intra-abdominal chemotherapy for the treatment of peritoneal carcinomatosis with curative intent.

CONTACT SPECIALIST

Complete the form and schedule your appointment to speak directly with the surgeon

  • EXTENSIVE EXPERIENCE +20,000 surgeries performed
  • LATEST TECHNOLOGY in surgical strategy
  • PERSONALIZED CARE First contact within 24-48h

Schedule your consultation with a specialist

EXPLANATORY VIDEO

Which cases need HIPEC?

Dr. Torrent explains in detail which patients are candidates for HIPEC treatment and how this procedure can significantly improve the prognosis in cases of peritoneal carcinomatosis.

  • Specific indications for the HIPEC procedure
  • Types of tumors that benefit from treatment
  • Patient selection criteria
Which cases need HIPEC?

What is HIPEC?

HIPEC (Hyperthermic Intraperitoneal Chemotherapy) is a procedure that combines cytoreductive surgery with the direct application of heated chemotherapy inside the abdominal cavity. It is used to treat tumors that have spread to the peritoneum (peritoneal carcinomatosis).

The goal is to remove all visible tumor implants through surgery and then apply heated chemotherapy to destroy residual microscopic cancer cells. Hyperthermia (heat) enhances the penetration and effect of chemotherapeutic drugs in tumor tissue.

How is the HIPEC procedure performed?

The HIPEC procedure is performed in the operating room under general anesthesia and consists of several phases:

1. Surgical exploration

Complete evaluation of the abdominal cavity to determine the extent of disease and calculate the peritoneal carcinomatosis index (PCI).

2. Complete cytoreduction

Removal of all visible tumor implants, including peritonectomies and resection of affected organs if necessary.

3. HIPEC application

Perfusion of the abdominal cavity with chemotherapy heated to 41-43°C for 60-90 minutes, ensuring contact with all peritoneal surfaces.

4. Reconstruction

Performing intestinal anastomoses and closing the abdominal cavity after draining the chemotherapy solution.

When is HIPEC indicated?

HIPEC is especially indicated for the following tumors with peritoneal involvement:

Pseudomyxoma peritonei

Mucinous appendicular tumors with peritoneal spread. This is the indication with the best results, achieving long-term survival rates above 80%.

Peritoneal mesothelioma

Primary tumor of the peritoneum where HIPEC has demonstrated significant survival benefit when complete cytoreduction is achieved.

Ovarian cancer

HIPEC has shown benefit in advanced ovarian cancer, especially in the context of interval surgery after neoadjuvant chemotherapy.

Colorectal carcinomatosis

In selected cases of colorectal carcinomatosis with low tumor burden and favorable biology.

Benefits of HIPEC treatment

HIPEC offers unique advantages in the treatment of peritoneal carcinomatosis:

Intensive local treatment

Chemotherapy is administered directly where the disease is located, reaching concentrations up to 20 times higher than systemic chemotherapy.

Lower systemic toxicity

When applied locally, systemic side effects are fewer than with conventional intravenous chemotherapy.

Synergistic effect of heat

Hyperthermia increases the penetration and effectiveness of chemotherapeutic drugs in tumor tissue.

Curative potential

In selected indications, HIPEC offers the possibility of cure in patients who previously only had palliative options.

Our experience in HIPEC

At Quenet-Torrent Institute we have one of the largest national and international experiences in cytoreductive surgery and HIPEC. Our team has performed more than 300 HIPEC procedures with oncological results published in high-impact scientific journals.

We work in a multidisciplinary environment that includes medical oncologists, radiologists, specialized anesthesiologists, and nursing staff with specific training in this complex procedure.

HIPEC specialists

Every physician at Quenet-Torrent Institute is a recognized expert in their field, committed to each patient's well-being.

Dr. François Quenet

Dr. François Quenet

Oncological Surgeon

View doctor
"Internationally renowned surgeon, expert in gastrointestinal and hepatobiliary tumors. Recognized for his precision in highly difficult surgeries."
Dr. Juan José Torrent

Dr. Juan José Torrent

Oncological Surgeon

View doctor
"Specialist in gynecological tumors and peritoneal carcinomatosis. A reference in complex and personalized oncological surgery."

Pathologies treated with HIPEC

The HIPEC procedure is used in the treatment of various pathologies with peritoneal involvement.

Peritoneal carcinomatosis

Comprehensive treatment of peritoneal tumor spread from various origins.

More information

Gynecological tumors

Especially indicated in advanced ovarian cancer with carcinomatosis.

More information

Colorectal tumors

In selected cases of colorectal carcinomatosis with favorable disease characteristics.

More information

Frequently asked questions about HIPEC

Answers to the most common questions about the HIPEC procedure.

What is HIPEC?

HIPEC combines cytoreductive surgery with direct application of heated chemotherapy (41-43°C) inside the abdominal cavity to treat peritoneal carcinomatosis.

For which tumors is HIPEC indicated?

Pseudomyxoma peritonei, peritoneal mesothelioma, advanced ovarian cancer, and selected cases of colorectal carcinomatosis Thorough preoperative assessment is essential for correct patient selection.

What is the advantage of HIPEC over systemic chemotherapy?

HIPEC delivers chemotherapy directly where the disease is, reaching concentrations up to 20 times higher than systemic chemotherapy, with lower systemic toxicity.

How long does the HIPEC procedure take?

The complete procedure — cytoreduction plus HIPEC — typically takes 6-12 hours depending on disease extent, with the HIPEC phase lasting an additional 30 to 90 minutes.

What are the risks of HIPEC?

It is a major surgery with inherent risks, but experienced teams and international protocols significantly minimize complications. Mortality is below 1-2% in specialized.

Need to speak with a specialist?

Complete the form and schedule your appointment to speak directly with the surgeon.

Request consultation